Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer With Brain Metastasis × neratinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Neoplasm Metastasis 10 Neoplasms 7 Brain Neoplasms 4 HER2-positive Breast Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Malignant Solid Tumors 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Recurrence 1 Rare Tumour 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1

Interventions

trastuzumab deruxtecan 2 neratinib 1 Radiosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07152782 2025-09-03

THUNDER

Fudan University

Phase 2 Not yet recruiting

Breast Cancer With Brain Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡